EC Number |
Inhibitors |
Structure |
---|
3.4.22.26 | more |
no inhibition by cystamine, benzoxycarbonyl-Val-Phe |
|
3.4.22.26 | more |
cystatin, alpha1-antiprotease, antithrombin III |
|
3.4.22.26 | more |
no inhibition by alpha2-macroglobulin, alpha1-antiprotease, antithrombin III/heparin, cystatin, cysteamine, alpha1-anichymotrypsin, the effectiveness of most of the inhibitors increase in presence of reducing agents |
|
3.4.22.26 | more |
inhibition by specific anti-CP antibodies |
|
3.4.22.26 | more |
no or poor inhibition by iodoacetamide and E-64 |
|
3.4.22.26 | Mn2+ |
above 1 mM, activates below 1 mM |
|
3.4.22.26 | Zn2+ |
in the presence of Ca2+, complete inactivation at 1 mM Zn2+ and above |
|
3.4.22.26 | Zn2+ |
inactivation |
|
3.4.22.26 | Cu2+ |
inactivation |
|
3.4.22.26 | Cu2+ |
1 mM: 46% decrease of activity (not statistically significant) |
|